Literature DB >> 3259983

Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis.

G Boire1, H A Ménard.   

Abstract

A group of 12 patients with rheumatoid arthritis (RA) with anti-Ro antibody were compared to an age and sex matched group with RA. Both had similar articular manifestations but the anti-Ro positive patients had more severe extraarticular as well as serological abnormalities. Vasculitis, liver abnormalities, neutropenia and circulating immune complexes were prominent while sicca features were not. Treatment with remission inducing drugs failed frequently without increased toxicity. Two patients with classical RA with anti-Ro developed subacute cutaneous lupus erythematosus and anti-dsDNA. Our observations suggest that the presence of anti-Ro in RA sera may be a marker for a small but significant subset of rheumatoid disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259983

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Multiple tendon ruptures in a patient affected by anti-SSA/Ro antibody positive rheumatoid arthritis.

Authors:  P Caramaschi; D Biasi; A Carletto; T Manzo; M Randon; M L Pacor; L M Bambara
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

2.  Chronic destructive monoarthritis of the wrist in patients with anti-SSA/Ro antibodies: report of two cases.

Authors:  M Satoh; H Yamagata; F Watanabe; Y Matsushita; S Nakayama; K Okubo; M Akizuki
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

3.  Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus.

Authors:  Márcio Veronesi Fukuda; Simone Chinwa Lo; Cláudia Salvini de Almeida; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2008-11-25       Impact factor: 2.980

4.  Antinuclear antibodies in routine analysis: the relevance of putative clinical associations.

Authors:  A J Swaak; V Huysen; R J Smeenk
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

5.  Clinical significance of anti-Ro antibodies in rheumatoid arthritis.

Authors:  Emilce Schneeberger; Gustavo Citera; Monica Heredia; José Maldonado Cocco
Journal:  Clin Rheumatol       Date:  2008-01-08       Impact factor: 2.980

6.  Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Shoji Sugii; Atsushi Hashimoto; Akiko Komiya; Naoshi Fukui; Tatsuo Nagai; Shunsei Hirohata; Keigo Setoguchi; Akira Okamoto; Noriyuki Chiba; Eiichi Suematsu; Taiichiro Miyashita; Kiyoshi Migita; Akiko Suda; Shouhei Nagaoka; Naoyuki Tsuchiya; Shigeto Tohma
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.